|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-amyloid fibril growth: Experimental studies and kinetic models
1 Department of Chemical and Biological Engineering, University of Wisconsin, Madison, Wisconsin 53706, USA
2 Department of Physics and 3 Department of Chemistry, Institute for Biophysical Dynamics, and the James Franck Institute, University of Chicago, Chicago, Illinois 60637, USA
(RECEIVED May 3, 2004; FINAL REVISION July 21, 2004; ACCEPTED July 22, 2004)
Aggregation of
-amyloid (A
) into fibrillar deposits is widely believed to initiate a cascade of adverse biological responses associated with Alzheimers disease. Although it was once assumed that the mature fibril was the toxic form of A
, recent evidence supports the hypothesis that A
oligomers, intermediates in the fibrillogenic pathway, are the dominant toxic species. In this work we used urea to reduce the driving force for A
aggregation, in an effort to isolate stable intermediate species. The effect of urea on secondary structure, size distribution, aggregation kinetics, and aggregate morphology was examined. With increasing urea concentration,
-sheet content and the fraction of aggregated peptide decreased, the average size of aggregates was reduced, and the morphology of aggregates changed from linear to a globular/linear mixture and then to globular. The data were analyzed using a previously published model of A
aggregation kinetics. The model and data were consistent with the hypothesis that the globular aggregates were intermediates in the amyloidogenesis pathway rather than alternatively aggregated species. Increasing the urea concentration from 0.4 M to 2 M decreased the rate of filament initiation the most; between 2 M and 4 M urea the largest change was in partitioning between the nonamyloid and amyloid pathways, and between 4 M and 6 M urea, the most significant change was a reduction in the rate of filament elongation.
Keywords: amyloid;
-amyloid; light scattering; atomic force microscopy; peptide aggregation
Abbreviations: A
,
-amyloid AFM, atomic force microscopy CD, circular dichroism, DLS, dynamic light scattering PrP, prion protein SEC, size exclusion chromatography
Reprint requests to: Regina M. Murphy, Department of Chemical and Biological Engineering, University of Wisconsin, 1415 Engineering Drive, Madison, WI 53706, USA; e-mail: murphy{at}che.wisc.edu; fax: (608) 262-5434.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Lee, E. J. Fernandez, and T. A. Good Role of aggregation conditions in structure, stability, and toxicity of intermediates in the Abeta fibril formation pathway Protein Sci., April 1, 2007; 16(4): 723 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. A. Vitrenko, E. O. Gracheva, J. E. Richmond, and S. W. Liebman Visualization of Aggregation of the Rnq1 Prion Domain and Cross-seeding Interactions with Sup35NM J. Biol. Chem., January 19, 2007; 282(3): 1779 - 1787. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-R. Chen and C. G. Glabe Distinct Early Folding and Aggregation Properties of Alzheimer Amyloid-beta Peptides Abeta40 and Abeta42: STABLE TRIMER OR TETRAMER FORMATION BY Abeta42 J. Biol. Chem., August 25, 2006; 281(34): 24414 - 24422. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |